Scopus:
Synthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors

dc.contributor.authorErdoğan, M.
dc.contributor.authorCavus, S.M.
dc.contributor.authorMuğlu, H.
dc.contributor.authorYakan, H.
dc.contributor.authorTürkes, C.
dc.contributor.authorDemir, Y.
dc.contributor.authorBeydemir, S.
dc.date.accessioned2023-12-08T13:53:48Z
dc.date.available2023-12-08T13:53:48Z
dc.date.issued2023
dc.description.abstractEleven new thiosemicarbazone derivatives (1–11) were designed from nine different biologically and pharmacologically important isothiocyanate derivatives containing functional groups such as fluorine, chlorine, methoxy, methyl, and nitro at various positions of the phenyl ring, in addition to the benzyl unit in the molecular skeletal structure. First, their substituted-thiosemicarbazide derivatives were synthesized from the treatment of isothiocyanate with hydrazine to synthesize the designed compounds. Through a one-step easy synthesis and an eco-friendly process, the designed compounds were synthesized with yields of up to 95 % from the treatment of the thiosemicarbazides with aldehyde derivatives having methoxy and hydroxy groups. The structures of the synthesized molecules were elucidated with elemental analysis and FT–IR, 1H-NMR, and 13C-NMR spectroscopic methods. The electronic and spectroscopic properties of the compounds were determined by the DFT calculations performed at the B3LYP/6-311++G(2d,2p) level of theory, and the experimental findings were supported. The effects of some global reactivity parameters and nucleophilic-electrophilic attack abilities of the compounds on the enzyme inhibition properties were also investigated. They exhibited a highly potent inhibition effect on acetylcholinesterase (AChE) and carbonic anhydrases (hCAs) (KI values are in the range of 23.54±4.34 to 185.90±26.16 nM, 103.90±23.49 to 325.90±77.99 nM, and 86.15±18.58 to 287.70±43.09 nM for AChE, hCA I, and hCA II, respectively). Furthermore, molecular docking simulations were performed to explain each enzyme-ligand complex's interaction.
dc.identifier10.1002/cbdv.202301063
dc.identifier.doi10.1002/cbdv.202301063
dc.identifier.issn16121872
dc.identifier.issue11
dc.identifier.pubmed37769192
dc.identifier.scopus2-s2.0-85174602710
dc.identifier.urihttps://hdl.handle.net/20.500.12597/17952
dc.identifier.volume20
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofChemistry and Biodiversity
dc.relation.ispartofseriesChemistry and Biodiversity
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleSynthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors
dc.typearticle
dspace.entity.typeScopus
oaire.citation.issue11
oaire.citation.volume20
person.affiliation.nameKafkas Üniversitesi
person.affiliation.nameKastamonu University
person.affiliation.nameKastamonu University
person.affiliation.nameOndokuz Mayis Üniversitesi
person.affiliation.nameErzincan Binali Yıldırım Üniversitesi
person.affiliation.nameArdahan Üniversitesi
person.affiliation.nameAnadolu Üniversitesi
person.identifier.orcid0000-0003-3216-1098
person.identifier.scopus-author-id57195289179
person.identifier.scopus-author-id36561034600
person.identifier.scopus-author-id56195892800
person.identifier.scopus-author-id46462159400
person.identifier.scopus-author-id55857860900
person.identifier.scopus-author-id57208078744
person.identifier.scopus-author-id6603903192

Files